BMRN vs DAIO · P/E 40, rev $1.76B vs rev $21.5M
Biomarin Pharmaceutical Inc (BMRN) versus Data I/O Corporation (DAIO) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Data I/O Corporation (DAIO) is a electronic components company listed on US.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported DAIO revenue for 2025-12-31 was $21.5M. Net income was -$5.2M. Revenue was down 1.2% from 2024-12-31 to 2025-12-31. DAIO currently screens at market cap $28.1M.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. DAIO currently screens at market cap $28.1M.
Not investment advice. Open the BMRN and DAIO stock pages for the full models.
Not investment advice.